# Breast reconstruction: implant and autologous, immediate and delayed, and what women report afterwards

Source: https://onco.cc/technologies/rejuv-recon-breast/  
OnCo record `rejuv-recon-breast` (Technology). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Two years after surgery, women reconstructed from their own tissue reported more satisfaction with their breasts than women with implants, by about 8 points on a 100-point scale. After radiotherapy the gap widens and so does the complication rate: 38.9 per cent of irradiated implant reconstructions had a complication within two years against 25.6 per cent of tissue ones.

## Summary

The corpus already holds `breast-reconstruction` as a glossary term describing what the operations are. This record is about what happens afterwards, measured with the instrument the field agreed on.

The instrument. The BREAST-Q was developed by Pusic and colleagues and field tested with 1,950 women at five centres in the United States and Canada, with a 72 per cent response rate. It produces independent 0 to 100 scales for satisfaction with breasts, psychosocial well-being, physical well-being and sexual well-being, each with a preoperative and postoperative version. It is the reason the comparisons below are comparable at all.

Implant against own tissue. The Mastectomy Reconstruction Outcomes Consortium recruited 2,013 women having immediate reconstruction at 11 centres across North America between 2012 and 2015, 1,490 with implants and 523 with their own tissue, and 1,217 (60.5 per cent) returned questionnaires at two years. After adjustment for baseline characteristics, autologous reconstruction scored higher on satisfaction with breasts by 7.94 points (5.68 to 10.20), on psychosocial well-being by 3.27 (1.25 to 5.29) and on sexual well-being by 5.53 (2.95 to 8.11). A separate single-centre series of 3,268 patients followed to eight years found the same direction at every time point, and added a finding that matters for counselling: implant satisfaction scores stayed stable over the years rather than falling.

Radiotherapy changes the arithmetic. In the same consortium, 622 irradiated and 1,625 unirradiated patients were compared. At least one breast complication within two years occurred in 38.9 per cent of irradiated patients with implants, 25.6 per cent of irradiated patients with autologous reconstruction, 21.8 per cent of unirradiated patients with implants and 28.3 per cent of unirradiated patients with autologous reconstruction. Among irradiated patients, autologous reconstruction carried a lower complication risk than implants (odds ratio 0.47, 0.27 to 0.82); among unirradiated patients there was no difference between the two. Satisfaction followed the same interaction: in irradiated patients the adjusted satisfaction scores were 63.5 for autologous against 47.7 for implant, a gap of about 16 points, against 67.6 versus 60.5 in unirradiated patients. Immediate reconstruction was also much less common in the irradiated group (83.0 against 95.7 per cent).

A larger claims analysis of 14,894 women treated between 1998 and 2007 gives the background rates in ordinary practice rather than at centres of excellence: wound complications within two years in 2.3 per cent with no reconstruction, 4.4 per cent with implants and 9.5 per cent with autologous tissue; infection in 12.7, 20.5 and 20.7 per cent. Radiation was associated with higher odds of implant removal in months 7 to 24 (odds ratio 1.48) and of fat necrosis after autologous reconstruction (1.55).

What is done in England. A Hospital Episode Statistics cohort of 16,890 women having unilateral mastectomy with immediate reconstruction in English NHS hospitals between 2009 and 2015 breaks the operations down: implant 30.7 per cent, tissue expander 16.7 per cent, autologous latissimus dorsi flap 14.0 per cent, latissimus dorsi with expander or implant 18.4 per cent and abdominal free flap 20.1 per cent. The same study found abdominal free flap the most expensive over eight years, driven by the index operation, while implant-based procedures accumulated more cost in revisions and secondary reconstructions.

What comes back, and when: appearance and the ability to wear ordinary clothes come back for most women, and the patient-reported scores say so. Sensation in the reconstructed breast usually does not, because the nerves to the skin are cut at mastectomy, and the trials above did not measure it. Reconstruction is also not one operation: revision procedures are the norm rather than a complication, and the English cost data show that directly.

## Fields

- Kind: Technology
- Status: standard-of-care
- Last checked: 2026-10-02
- Tags: rejuvenation; survivorship; rehabilitation; evidence:strong
- Principle: An implant replaces volume without blood supply of its own, so it depends on the quality of the skin envelope over it, which is exactly what radiotherapy degrades. An autologous flap brings its own artery and vein, so it tolerates an irradiated bed and ages with the patient, at the price of a second wound at the donor site and a longer operation. That single difference explains almost every result above.
- Strengths: Compared in a prospective multicentre cohort with a validated instrument; The interaction with radiotherapy is quantified and can be used in counselling; Implant satisfaction stays stable over years rather than declining
- Limitations: Two-year follow-up in the consortium and 60.5 per cent questionnaire return; Sensation in the reconstructed breast is not restored and is not measured in these studies; Revision surgery is common and is a cost and a burden rather than a rare event

## Sources

- Wikipedia: https://en.wikipedia.org/wiki/Breast_reconstruction
- Long-term patient-reported outcomes in postmastectomy breast reconstruction (JAMA Surg 2018): https://doi.org/10.1001/jamasurg.2018.1677
- Impact of radiotherapy on complications and patient-reported outcomes after breast reconstruction (JNCI 2018): https://doi.org/10.1093/jnci/djx148
- Development of a new patient-reported outcome measure for breast surgery: the BREAST-Q (Plast Reconstr Surg 2009): https://doi.org/10.1097/PRS.0b013e3181aee807
- Long-term patient-reported outcomes following postmastectomy breast reconstruction: an 8-year examination of 3,268 patients (Ann Surg 2019): https://doi.org/10.1097/SLA.0000000000003467
- Complications after mastectomy and immediate breast reconstruction for breast cancer: a claims-based analysis (Ann Surg 2016): https://doi.org/10.1097/SLA.0000000000001177
- Secondary healthcare costs after mastectomy and immediate breast reconstruction in England (Br J Surg 2023): https://doi.org/10.1093/bjs/znad149

## Connected records

- cancers: [HER2-positive breast cancer](https://onco.cc/cancers/breast-her2-positive/), [HR-positive / HER2-negative breast cancer](https://onco.cc/cancers/breast-hr-positive/), [Triple-negative breast cancer (TNBC)](https://onco.cc/cancers/tnbc/)
- fronts: [Recovery & Rejuvenation](https://onco.cc/fronts/rejuvenation/), [Surgery & Interventional](https://onco.cc/fronts/surgery/)
- technologies: [Cancer rehabilitation: the discipline that puts function back](https://onco.cc/technologies/rejuv-rehab-cancer-rehabilitation/), [Compression, decongestive therapy and exercise for lymphoedema](https://onco.cc/technologies/lymphoedema-decongestive-therapy/), [Head and neck reconstruction: the free flap, and what it gives back](https://onco.cc/technologies/rejuv-recon-head-neck/), [IMRT / IGRT (modern external beam)](https://onco.cc/technologies/imrt-igrt/), [Scars, stiffness and contracture: shoulders, necks and jaws](https://onco.cc/technologies/rejuv-rehab-scar-contracture/), [The devices that do the restoring, and who pays for them](https://onco.cc/technologies/rejuv-rehab-assistive-devices/)
- terms: [Breast reconstruction](https://onco.cc/terms/breast-reconstruction/), [Late effects and survivorship toxicity](https://onco.cc/terms/late-effects/), [Quality of life](https://onco.cc/terms/quality-of-life/)
- bottlenecks: [Survivorship and late effects are neglected](https://onco.cc/bottlenecks/b-survivorship/), [Toxicity and quality of life are undervalued](https://onco.cc/bottlenecks/b-toxicity-qol/)

---
JSON: https://onco.cc/api/v1/entities/rejuv-recon-breast.json